{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:23:14Z","timestamp":1782307394745,"version":"3.54.5"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda (English Edition)"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.anpede.2022.07.001","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T03:50:46Z","timestamp":1659153046000},"page":"190-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness and safety of bisphosphonates therapy in secondary osteoporosis in children"],"prefix":"10.1016","volume":"97","author":[{"given":"Roc\u00edo","family":"Galindo Zavala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Bou-Torrent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Mir-Perell\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad","family":"Mart\u00ednez Regueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berta","family":"Magallares-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"L\u00f3pez-Corbeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpede.2022.07.001_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.anpedi.2014.05.003","article-title":"Advances in the treatment of secondary osteoporosis","volume":"81","author":"Galindo Zavala","year":"2014","journal-title":"An Pediatr"},{"key":"10.1016\/j.anpede.2022.07.001_bib0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jocd.2014.01.007","article-title":"2013 Pediatric Position Development Conference: executive summary and reflections","volume":"17","author":"Gordon","year":"2014","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.anpede.2022.07.001_bib0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jpc.13768","article-title":"Consensus guidelines on the use of bisphosphonate therapy in children and adolescents","volume":"54","author":"Simm","year":"2018","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.anpede.2022.07.001_bib0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000329151","article-title":"Bisphosphonate therapy in children with secondary osteoporosis","volume":"76 Suppl 1","author":"Papapoulos","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.anpede.2022.07.001_bib0025","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/jc.2008-1531","article-title":"Clinical review 1: Bisphosphonate use in childhood osteoporosis","volume":"94","author":"Bachrach","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.anpede.2022.07.001_bib0030","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s40265-017-0715-3","article-title":"Pediatric osteoporosis: diagnosis and treatment considerations","volume":"77","author":"Marrani","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.anpede.2022.07.001_bib0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12969-020-0411-9","article-title":"Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children","volume":"18","author":"Galindo-Zavala","year":"2020","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.anpede.2022.07.001_bib0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bone.2019.01.003","article-title":"Outcomes following intravenous bisphosphonate infusion in pediatric patients: a 7-year retrospective chart review","volume":"121","author":"Nasomyont","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.anpede.2022.07.001_bib0045","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jocd.2019.07.001","article-title":"Executive Summary of the 2019 ISCD Position Development Conference on Monitoring Treatment, DXA Cross-calibration and Least Significant Change, Spinal Cord Injury, Peri-prosthetic and Orthopedic Bone Health, Transgender Medicine, and Pediatrics","volume":"22","author":"Shuhart","year":"2019","journal-title":"J Clin Densitom Off J Int Soc Clin Densitom"},{"key":"10.1016\/j.anpede.2022.07.001_bib0050","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1210\/jc.2009-2057","article-title":"Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children","volume":"95","author":"Zemel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.anpede.2022.07.001_bib0055","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00198-019-05227-9","article-title":"Intravenous bisphosphonate therapy in children with spinal muscular atrophy","volume":"31","author":"Nasomyont","year":"2020","journal-title":"Osteoporos Int a J Establ as result Coop between Eur Found Osteoporos Natl Osteoporos Found U S A"},{"key":"10.1016\/j.anpede.2022.07.001_bib0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12969-018-0258-5","article-title":"Early use of alendronate as a protective factor against the development of glucocorticoid-induced bone loss in childhood-onset rheumatic diseases: a cross-sectional study","volume":"16","author":"Inoue","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.anpede.2022.07.001_bib0065","first-page":"1445","article-title":"Smoking & bone","volume":"26","author":"Watanabe","year":"2016","journal-title":"Clin Calcium"},{"key":"10.1016\/j.anpede.2022.07.001_bib0070","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3345\/kjp.2017.60.12.403","article-title":"The effect of low-dose intravenous bisphosphonate treatment on osteoporosis in children with quadriplegic cerebral palsy","volume":"60","author":"Moon","year":"2017","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.anpede.2022.07.001_bib0075","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005324.pub2","article-title":"Bisphosphonate therapy for children and adolescents with secondary osteoporosis","author":"Ward","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anpede.2022.07.001_bib0080","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/cid\/ciz957","article-title":"Alendronate improves bone mineral density in children and adolescents perinatally infected with human immunodeficiency virus with low bone mineral density for age","volume":"71","author":"Jacobson","year":"2020","journal-title":"Clin Infect Dis an Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.anpede.2022.07.001_bib0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.eclinm.2019.06.004","article-title":"The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: a randomised double-blind controlled trial","volume":"12","author":"Rooney","year":"2019","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.anpede.2022.07.001_bib0090","doi-asserted-by":"crossref","DOI":"10.1007\/s00198-021-05845-2","article-title":"Does treatment with bisphosphonates protect against fractures in real life? The HUNT study, Norway","author":"Hoff","year":"2021","journal-title":"Osteoporos Int a J Establ as result Coop between Eur Found Osteoporos Natl Osteoporos Found U S A"},{"key":"10.1016\/j.anpede.2022.07.001_bib0095","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00198-010-1461-5","article-title":"Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement","volume":"22","author":"Leslie","year":"2011","journal-title":"Osteoporos Int a J Establ as result Coop between Eur Found Osteoporos Natl Osteoporos Found U S A"},{"key":"10.1016\/j.anpede.2022.07.001_bib0100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/adc.2004.053553","article-title":"Bone mass acquisition in healthy children","volume":"90","author":"Davies","year":"2005","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.anpede.2022.07.001_bib0105","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fendo.2020.00200","article-title":"The bones of children with obesity","volume":"11","author":"Fintini","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.anpede.2022.07.001_bib0110","first-page":"179","article-title":"Zoledronic acid versus alendronate in the treatment of children with osteogenesis imperfecta: a 2-year clinical study","volume":"24","author":"Lv","year":"2018","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"}],"container-title":["Anales de Pediatr\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287922001533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341287922001533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:45:23Z","timestamp":1762422323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2341287922001533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2341287922001533"],"URL":"https:\/\/doi.org\/10.1016\/j.anpede.2022.07.001","relation":{},"ISSN":["2341-2879"],"issn-type":[{"value":"2341-2879","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of bisphosphonates therapy in secondary osteoporosis in children","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpede.2022.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2021.09.008","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}